AstraZeneca and insitro Sign AI Drug Discovery Collaboration

AstraZeneca announced a drug-discovery collaboration and licensing agreement with insitro to identify potential treatments for liver and heart diseases. insitro will receive $40 million upfront and is eligible for additional payments.